199 related articles for article (PubMed ID: 11234138)
41. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
42. A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Maltz MB; Dymond DS; Nathan AW; Camm AJ
Eur Heart J; 1987 Dec; 8 Suppl M():37-42. PubMed ID: 2967184
[TBL] [Abstract][Full Text] [Related]
43. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
Schwartz JB; Jackson G; Kates RE; Harrison DC
Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
[TBL] [Abstract][Full Text] [Related]
44. [Efficacy of native carvedilol in patients with essential hypertension].
Yang T; Zhang Z; Jia Z; Lin S; Peng Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):153-6. PubMed ID: 11938776
[TBL] [Abstract][Full Text] [Related]
45. Effect of atenolol in angina pectoris of effort.
Hernández-Cañero A; González A; Cardonne A; Pérez-Medina T; Garcia-Barreto D
Cor Vasa; 1972; 20(2):99-103. PubMed ID: 4499921
[TBL] [Abstract][Full Text] [Related]
46. Atenolol in the treatment of angina pectoris.
Erikssen J; Osvik K; Dedichen J
Acta Med Scand; 1977; 201(6):579-84. PubMed ID: 17996
[TBL] [Abstract][Full Text] [Related]
47. Carvedilol.
Frishman WH
N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
[No Abstract] [Full Text] [Related]
48. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans.
Herman RB; Jesudason PJ; Mustafa AM; Husain R; Choy AM; Lang CC
Br J Clin Pharmacol; 2003 Feb; 55(2):134-8. PubMed ID: 12580984
[TBL] [Abstract][Full Text] [Related]
49. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Pehrsson SK; Ringqvist I; Ekdahl S; Karlson BW; Ulvenstam G; Persson S
Clin Cardiol; 2000 Oct; 23(10):763-70. PubMed ID: 11061055
[TBL] [Abstract][Full Text] [Related]
50. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
[TBL] [Abstract][Full Text] [Related]
51. Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
de Vries RJ; van den Heuvel AF; Lok DJ; Claessens RJ; Bernink PJ; Pasteuning WH; Kingma JH; Dunselman PH
Int J Cardiol; 1996 Dec; 57(2):143-50. PubMed ID: 9013266
[TBL] [Abstract][Full Text] [Related]
52. Treatment of chronic stable angina with carvedilol: a multiple-action neurohormonal antagonist. A review of controlled clinical trials.
González Maqueda I
J Int Med Res; 1998; 26(3):107-19. PubMed ID: 9718465
[TBL] [Abstract][Full Text] [Related]
53. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
54. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
Am J Cardiol; 1985 Jul; 56(1):35-40. PubMed ID: 2861738
[TBL] [Abstract][Full Text] [Related]
56. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of carvedilol in unstable angina pectoris.
Brunner M; Faber TS; Greve B; Keck A; Schnabel P; Jeron A; Meinertz T; Just H; Zehender M
Am J Cardiol; 2000 May; 85(10):1173-8. PubMed ID: 10801996
[TBL] [Abstract][Full Text] [Related]
58. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
Ruf G; Trenk D; Jähnchen E; Roskamm H
Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
[TBL] [Abstract][Full Text] [Related]
59. A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris.
Metcalfe MJ; Jennings K
Curr Med Res Opin; 1995; 13(5):251-6. PubMed ID: 7555033
[TBL] [Abstract][Full Text] [Related]
60. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Fitscha P; Meisner W; Tiso B
Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
